Modificare „PAVmed Inc.”

Pagina dedicata companiei PAVmed Inc. listata cu simbolul US.PAVM

==Descriere companie==
PAVmed Inc. (http://www.pavmed.com/) is a multi-product, commercial-stage technology medical device company. The Company has four operating divisions. GI Health division includes EsoGuard, EsoCheck and EsoCure. EsoGuard and EsoCheck have been developed to provide non-invasive, patient-friendly screening test for the early detection of adenocarcinoma of the esophagus (EAC) and Barrett's Esophagus (BE), including dysplasia and related pre-cursors to EAC in patients with chronic gastroesophageal reflux (GERD). EsoCure is in development as an Esophageal Ablation Device with the intent to allow a clinician to treat dysplastic BE before it can progress to EAC. Minimally Invasive Interventions division offers CarpX, a minimally invasive surgical device for carpal tunnel syndrome. Infusion Therapy division includes PortIO, which is an implantable, intraosseous vascular access device, and NextFlo, which is a disposable, infusion platform technology that includes intravenous infusion sets and disposable infusion pumps.

==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.PAVM" />

==Ultimele stiri despre PAVmed Inc. (US.PAVM)==
<dynamicpagelist>
category=US.PAVM
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>

[[Categorie:US.PAVM]][[Categorie:Stiri despre companii]]